196-210 of 825
Next Steps in Gene Therapy Research for Duchenne Muscular Dystrophy
NeuroFrontiersNext Steps in Gene Therapy Research for Duchenne Muscular Dystrophy
Craig M. McDonald, MD
Monitoring Multiple Sclerosis: The Role of Serum Neurofilament Light Chain Levels
NeuroFrontiersMonitoring Multiple Sclerosis: The Role of Serum Neurofilament Light Chain Levels
Engineering Autoimmunity: A New Model for Studying MS Progression and Remyelination
NeuroFrontiersEngineering Autoimmunity: A New Model for Studying MS Progression and Remyelination
Christian Cordano, MD, PhD
Advances in MS Management: Current and Future Directions
NeuroFrontiersAdvances in MS Management: Current and Future Directions
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
NeuroFrontiersDiagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
Nancy Kuntz, MD
Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
NeuroFrontiersDuchenne Muscular Dystrophy Management: Analyzing Current Approaches
Nancy Kuntz, MD
- advertisement
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
NeuroFrontiersFrom Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
Ashley Baker, MSN, PMHNP
Steven Paul, MD
Exploring Metabolomics in Multiple Sclerosis
NeuroFrontiersExploring Metabolomics in Multiple Sclerosis
Pavan Barghava, MD
Metabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
NeuroFrontiersMetabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
Pavan Barghava, MD
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
NeuroFrontiersSafety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
Amber Salter, PhD
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
NeuroFrontiersMS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
Michael Kornberg, MD, PhD
Managing Multiple Sclerosis: The Impact of Dietary Modifications
On the Frontlines of Multiple SclerosisManaging Multiple Sclerosis: The Impact of Dietary Modifications
Charles Turck, PharmD, BCPS, BCCCP
Anna A. Shah, MD
- advertisement
Strategies and Considerations for Managing MS in Pregnant Women
On the Frontlines of Multiple SclerosisStrategies and Considerations for Managing MS in Pregnant Women
Charles Turck, PharmD, BCPS, BCCCP
Anna A. Shah, MD
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
NeuroFrontiersCognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
Christopher Lock, MD
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
NeuroFrontiersUnderstanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
Dalia Rotstein, MD, MPH
